July 2012 FDA Recall Ventolin by Glaxosmithkline Inc
D-1666-2012 - Does Not Deliver Proper Metered Dose

This Class II drug recall was voluntarily initiated by Glaxosmithkline Inc on July 26, 2012 for the product Ventolin. The FDA reported the reason for recall as does not deliver proper metered dose. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1666-2012

Reason for Recall
Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification.
Initiated
07-26-2012
Reported
09-05-2012
Quantity
1,412,566 inhalers

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Ventolin HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation, 200 Metered Inhalations, FOR ORAL INHALATION ONLY - For use with Ventolin HFA actuator only. Net. wt. 18 g Rx only, GlaxoSmithKline, Reasearch Triangle Park, NC 27709 NDC 0173-0682-20

Batch or Lot Expiration Information

Lot# Lot 1ZP7355 Exp. 01/13, 1ZP7749 Exp. 01/13, 1ZP8141 Exp. 01/13, 1ZP8147 Exp. 01/13, 1ZP7729 Exp. 01/13, 1ZP0414 Exp. 03/13, 1ZP0464 Exp. 03/13, 1ZP0570 Exp. 03/13, 1ZP0576 Exp. 03/13, 1ZP0919 Exp. 03/13, 2ZP4959 Exp. 04/13, 2ZP4966 Exp. 04/13

Affected Packages Involved in this Recall